TORONTO - Canada's main stock index saw gains Thursday, helped by strength in base metals stocks, while U.S. markets also ...

Altimmune, Inc.'s Pemvidutide shows promise in MASH treatment with liver improvements and safety, despite market overreaction. Click for my ALT stock update.

The S&P 500 Quality FCF Aristocrats seeks out S&P 500 companies that have all of the following traits: High free cash flow ...

Canada was ranked the fifth-most investment-curious country in a recent study, with higher-risk investments like stocks and ...

Have you ever been faced with a difficult decision and been told to “sleep on it”? A new study shows there’s actually ...

Denali Therapeutics remains an intriguing clinical-stage biotech focused on neurodegenerative and lysosomal storage diseases.

In its Global Trade Update (May 2025), the UN Conference on Trade and Development (UNCTAD) cautioned that a lack of copper ...

As an aging cohort of financial advisors prepares for retirement, firms are scrambling for next-gen talent. Yet a new study ...

Tilray Brands (NasdaqGS:TLRY) has recently published a scientific study through its medical division, comparing the bioavailability of different cannabinoid formulations. This event, paired with the ...

Britain's trees are evolving resistance to the deadly ash dieback fungus, scientists have revealed. The disease has wrought havoc on the countryside, leaving behind the remains of dying ash trees.

It officially takes parents two and a half days to recover from traveling with the family, according to new research.

Last year’s strong stock-market returns may drive more foundation giving in 2025, and fundraisers should focus on DAF donors.